Science:Life Sciences
One of the challenges to securing the participation of patients in clinical trials can be simple geography. Sanguine Biosciences is seeking to tear down that barrier to participation by using mobile technology to bring clinical trials to patients. The company recently partnered with Vir Biotechnology to complete a COVID-19 clinical study aimed at better understanding the biology of the disease by sending healthcare personnel to collect blood samples from patients at their homes. We spoke to Brain Neman, co-founder and CEO of Sanguine, about it use of digital health technologies, how the company works, and its recent collaboration with Vir Biotechnology for a COVID-19 study.
view more
More Episodes
Making A Social Contract That’s Enforceable
2020-03-12
2020-03-12
Fishing for New Drugs
2020-02-27
2020-02-27
Quantifying Neurodegeneration with Precision
2020-01-30
2020-01-30
Reversing Disease Signals
2020-01-16
2020-01-16
Turning Cold Tumors Hot
2020-01-09
2020-01-09
An Effort to Eradicate Preventable Blindness
2019-12-20
2019-12-20
Seeking Success Where Others Have Failed
2019-12-19
2019-12-19
Improving Health with Better Data
2019-12-05
2019-12-05
Get this podcast on your
phone, FREE
